Manifestations and Outcomes of Patients with Parkinson’s Disease and Serious Infection in the Emergency Department

Table 5

Presentation of inflammatory and organ dysfunction biomarkers in survivors and nonsurvivors of septic PD patients within 28 days of admission.

Biomarkers	Case numbers	Survivors	Nonsurvivors	P value
WBC (1000/mm^3), mean ± SD	1,105/86	11.9 ± 5.3	11.9 ± 6.4	0.976
Segment (%), mean ± SD	1,103/86	80.2 ± 10.8	77.4 ± 17.6	0.03
Lymphocyte (%), mean ± SD	1,103/86	12.4 ± 8.4	12.3 ± 12.9	0.959
Band form (%), mean ± SD	1,103/86	0.6 ± 2.1	3.1 ± 7.2	0.00
C-reactive protein (mg/dL), mean ± SD	914/71	79.2 ± 78.1	139.4 ± 120.5	<0.00
Lactate (mg/dL), mean ± SD	220/38	21.9 ± 14.9	43.2 ± 52.0	0.01
BUN (mg/dL), mean ± SD	756/57	25.6 ± 20.0	39.8 ± 26.7	<0.00
Creatinine (mg/dL), mean ± SD	1,079/81	1.3 ± 1.1	1.5 ± 1.0	0.03
Bilirubin (mg/dL), mean ± SD	182/16	1.2 ± 1.2	1.9 ± 2.0	0.175

PD: Parkinson’s disease; WBC: white blood cells; SD: standard deviation; BUN: blood urea nitrogen
< 0.05